The autoimmune regulator (AIRE) gene is crucial for establishing central immunological tolerance and preventing autoimmunity. Mutations in AIRE cause a rare autosomal-recessive disease, autoimmune polyendocrine syndrome type 1 (APS-1), distinguished by multi-organ autoimmunity. We have identified multiple cases and families with mono-allelic mutations in the first plant homeodomain (PHD1) zinc finger of AIRE that followed dominant inheritance, typically characterized by later onset, milder phenotypes, and reduced penetrance compared to classical APS-1. These missense PHD1 mutations suppressed gene expression driven by wild-type AIRE in a dominant-negative manner, unlike CARD or truncated AIRE mutants that lacked such dominant capacity. Exome array analysis revealed that the PHD1 dominant mutants were found with relatively high frequency (>0.0008) in mixed populations. Our results provide insight into the molecular action of AIRE and demonstrate that disease-causing mutations in the AIRE locus are more common than previously appreciated and cause more variable autoimmune phenotypes.
Correspondence eystein.husebye@k2.uib.no In Brief This paper by Husebye and colleagues directly links heterozygous mutations in the autoimmune regulator (AIRE) gene to organ-specific autoimmunity, including APS-1. The authors show that these mutations cluster within the first PHD domain of AIRE and exert a dominantnegative effect on wild-type AIRE in vitro.
INTRODUCTION
The autoimmune regulator (AIRE) is a key player in shaping central immunological tolerance to self. AIRE is mainly expressed in medullary thymic epithelial cells (mTECs), but it is also expressed to some extent in rare hematopoietic populations of lymph nodes . In mTECs, AIRE induces the expression of thousands of tissue-restricted proteins, which are presented on major histocompatibility complex class I (MHC-I) and MHC-II molecules to developing T cells percolating through the thymic medulla. This ''projection of self'' by mTECs is essential for the elimination of auto-reactive T cells, either via clonal deletion (Taniguchi and Anderson, 2011) or via their conversion into Foxp3 + regulatory T cells (Cowan et al., 2013) ; a critical step for the induction of functional immunological tolerance to self and prevention of autoimmunity (Taniguchi and Anderson, 2011) .
In humans, mutations in AIRE cause autoimmune polyendocrine syndrome type 1 (APS-1), also called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), a rare autosomal-recessive disease characterized by autoimmune attack against peripheral (mainly endocrine) tissues, as well as by generation of various autoantibodies, including interferonspecific autoantibodies (Meager et al., 2006) . The majority of APS-1 patients develop at least two (diagnostic dyad) of the three main components, including adrenocortical insufficiency, hypoparathyroidism, and chronic mucocutaneous candidiasis (Ahonen et al., 1990; Husebye and Anderson, 2010) . In addition, premature ovarian insufficiency, pernicious anemia, vitiligo, alopecia, enamel hypoplasia, and keratitis are common components. The disease typically manifests in childhood, but milder forms with late onset are seen, which are not always initially recognized as APS-1.
About 100 APS-1-causing mutations have been found throughout AIRE (http://www.hgmd.cf.ac.uk; Ferguson et al., 2008) . All are assumed to be inherited in an autosomal-recessive manner, except for one mutation in the SAND domain, p.G228W, which follows a dominant inheritance pattern (Cetani et al., 2001) . Because AIRE is known to operate as a homo-oligomer (Kumar et al., 2001; Pitkä nen et al., 2000) , it is rather surprising that only one mono-allelic mutation in the AIRE locus has been linked to APS-1 and/or other forms of organ-specific autoimmune disorders so far.
Based on analysis of human patients followed by biochemical and population analyses, we report a group of novel mono-allelic AIRE mutations. These mutations clustered within the first plant homeodomain (PHD1) zinc finger domain and were associated with organ-specific autoimmune diseases of varying penetrance and severity, which often did not match the diagnostic criteria Tables S1 and S4. for APS-1. Furthermore, we delineated the molecular mode of action by which these unique mutations interfered with the function of wild-type (WT) AIRE protein. Our results provide insight into the molecular action of the AIRE protein and indicate that disease-causing mutations in the AIRE locus are much more common than previously thought and can cause more variable autoimmune phenotypes.
RESULTS

Novel p.C311Y AIRE Mutant Exerts a Dominant-Negative Effect
This study was initiated by the discovery of a heterozygous c.932G>A (p.C311Y) mutation in AIRE in a North-African patient (I:2; Figure 1A , Tables 1 and S1 ) diagnosed with adult-onset of chronic mucocutaneous candidiasis, adrenal insufficiency, enamel dysplasia, pernicious anemia, partial diabetes insipidus, and interferon omega autoantibodies ( Figure 1A ). Importantly, no other mutations or copy-number variations were detected. The patient's family history revealed a daughter (II:1, with partner 1) who had hypoparathyroidism, enamel dysplasia, primary ovarian insufficiency, autoimmune gastritis, pernicious anemia, and the same mono-allelic p.C311Y alteration indicating dominant inheritance. With his second partner (I:3), the patient had four children, three of whom carried the mono-allelic p.C311Y alteration and developed various forms of autoimmunity. One daughter (II:2) had alopecia areata and nail dystrophy on one of ten finger nails, another daughter (II:4) had hypoparathyroidism and primary ovarian insufficiency, and a son (II:3) was diagnosed with autoantibodies against tyrosine hydroxylase (often associated with APS-1) (Hedstrand et al., 2000) but no other autoimmune manifestations ( Figure 1A , Tables 1 and S1 ). To exclude autosomalrecessive inheritance at the AIRE locus, we performed microsatellite markers analysis, which confirmed that the affected children indeed inherited different maternal AIRE alleles ( Figures  1A and S1 ).
We next analyzed whether p.C311Y could repress the transcription-transactivation potential of WT AIRE in a dominantnegative manner. To this end we utilized the human thymic epithelial 4D6 cell line, which was transfected with either WT-AIRE and/or mutated AIRE expression vectors. Alterations in the CARD domain (p.L28P) and the major Finnish mutation (p.R257*) were used as recessive controls, and p.G228W was used as a dominant-negative control. We then measured the mRNA expression of a panel of AIRE-dependent (KRT14, S100A8, and IGFL1) and -independent (CCNH and PRMT3) genes (Giraud et al., 2012) . As expected, WT AIRE induced strong expression of all analyzed AIRE-dependent genes, whereas p.C311Y, p.G228W, p.L28P, and the deleterious major Finnish mutation p.R257* did not (Figures 1B and S2) . No differences among the WT AIRE or AIRE mutants were seen for AIREindependent genes (Figures 1B and S2) . Strikingly, when 4D6 cells were co-transfected with different ratios of WT AIRE and the above mutants, p.C311Y completely abolished the ability of WT AIRE to induce expression of AIRE-dependent genes (Figures 1B and S2) , as did the previously reported SAND domain mutant p.G228W (dominant-negative control) . Conversely, neither p.R257* nor the p.L28P CARD mutation showed this inhibiting effect (recessive controls). Taken together, these data validate that the p.C311Y mutant exerted a dominant-negative effect on WT AIRE function, both in vitro and in human patients.
Identification of Dominant-Negative Variants of AIRE Because the phenotype in family A segregated with a heterozygous mutation in AIRE with an inhibitory effect on transcription of AIRE-dependent genes, we asked whether there might be more dominant AIRE mutations. To test this hypothesis, we generated a panel of expression vectors with reported disease-causing mutations including several located in the PHD1, CARD, and SAND domains (Figure 2A ). First we tested the dominantnegative effect of AIRE mutants in co-transfection experiments with WT AIRE in 4D6 cells. Similarly to the p.C311Y alteration, virtually all missense alterations in the PHD1 finger, including p.E298K, p.V301M, p.C302Y, p.R303P, p.G305S, p.D312N, and p.P326L, revealed a dominant-negative effect on AIREdependent genes (Figures 2B and S3, Table S2 ). Interestingly, the dominant-negative effect of p.V301M varied with the downstream gene tested ( Figures 2B and S3) , which was surprising but reproducible in several independent experiments. In contrast, most of AIRE's CARD mutants, as well as the truncated PHD1 mutant p.C311*, revealed a clear recessive pattern, and the common p.C322del13, p.R328Q, and p.C446G displayed only a partial dominant effect (Figures 2B and S3, Table S2 ). Conversely, p.R471C (PHD2 domain) had no effect on AIREdependent gene transcription (Figures 2B and S3, Table S2 ). As expected, AIRE-independent transcriptional activity was not affected in any of these analyses (Figures 2B and S3) . For unknown reasons, WT and mutated AIRE induced higher levels of expression of the AIRE-dependent genes than WT alone for some of the mutants, in particular p.R257* (Figures 1B and 2B) .
This series of experiments demonstrated that the heterozygous mutations in AIRE could be segregated into three groups according to their potential to impact on the transcriptiontransactivation potential of WT AIRE in (1) dominant-negative, (2) recessive, and (3) partial dominant-negative manners. Moreover, our data revealed that most of the mutations operating in a dominant-negative manner were clustered within the PHD1 finger, while most recessive mutations were clustered within the CARD domain. Dominant-Negative Mutants Physically Co-localize with WT AIRE To better understand the unique properties of the dominant mutants, we next analyzed their nuclear localization patterns. 4D6 cells were co-transfected with red fluorescent protein (RFP)-tagged WT AIRE plasmids together with expression vectors encoding individual AIRE mutants tagged with enhanced green fluorescent protein (EGFP). Importantly, all dominant mutants, including the PHD1 missense mutations, localized in nuclear speckles typical for WT AIRE and co-localized with WT AIRE protein (yellow overlay) ( Figures 3A and S4 , Table S3 ). In contrast, recessive CARD mutants (p.L28P, p.LL28_29PP; p.Y90C; p.L97P), which are thought to disrupt AIRE homo-oligomerization (Kumar et al., 2001; Pitkä nen et al., 2001) , failed to provide the same speckled pattern and instead stained diffusely throughout the nucleus when transfected alone. In co-transfections, however, all CARD mutants partly co-localized with WT AIRE, indicating that when co-expressed, some functional oligomers are able to form.
Virtually all analyzed PHD1 mutants demonstrated a dominant-negative effect, so we sought to gain more insights about the impact of these mutants on molecular structure of this domain. Specifically, in silico analysis predicted that the p.C311 residue is crucial for chelating Zn 2+ and thereby is critical for correct folding of the PHD1 finger. Indeed, a substitution of the cysteine with tyrosine predicts disruption of PHD1 folding ( Figure 3B ; Chakravarty et al., 2009) . Additional structural analyses revealed that many of the reported missense mutations changed amino acids that were conserved among different species (Figures 3B and S5; Bjö rses et al., 2000; Org et al., 2008; Spiliotopoulos et al., 2012) and could similarly affect the Zn 2+ -binding or folding of the domain. Taken together, these data suggested that most of the PHD1 mutants could, unlike their CARD mutant counterparts, physically associate with WT AIRE in nuclear speckles and form a homo-oligomer, which was however not functional due to dysfunctional PHD1 fingers.
Proof of Concept: Additional PHD1 Dominant-Negative AIRE Mutations Segregate with Organ-Specific Autoimmunity Our in vitro analyses predicted that in addition to the p.C311Y alteration, more dominant mutations were clustered within the PHD1 finger and might therefore similarly cause organ-specific autoimmunity in human patients. To validate this hypothesis, we performed a thorough analysis of the patient cohorts available to us. First, we reinvestigated a previously described case, in which p.C311Y had been reported as a compound heterozygous mutation with p.R257* in two Finnish siblings with childhood-onset of APS-1 ( Table S1 ). In contrast, the third daughter (II:1), a heterozygous carrier of p.R257*, was without detectable autoantibodies.
Next, we reinvestigated a woman with APS-2 characterized by adrenal insufficiency, autoimmune thyroid disease, primary ovarian insufficiency, and autoantibodies characteristic of APS-I with a mono-allelic c.901G>A (p.V301M) mutation (Table 1 [family C], Figure 4A , and Table S1 ; Sö derbergh et al., 2000) . Her daughter (also with a p.V301M alteration) had autoantibodies against IL-17F, which are often found in APS-1 patients. However, she did not present with any additional autoimmune manifestations at age 30 years. Finally, additional screening of a large cohort of 85 Russian APS-1 patients and some of their family members identified a young girl with a mono-allelic p.C302Y mutation, who developed hypoparathyroidism and autoantibodies against interferon omega, NALP-5, and 21-hydroxylase (Tables 1 [subject D] and S1). Like p.C311Y, p.C302Y revealed dominant-negative effects on AIRE-mediated transcription (Figures 2B and S3 and Table  S2 ). A very similar case with a de novo mono-allelic p.C302Y alteration was reported by us earlier (Tables 1 [subject E] and S1; Oftedal et al., 2008) .
In summary, our data illustrated that individuals with bi-allelic disease-causing AIRE mutations developed classic early-onset APS-1 phenotypes, whereas those carrying one of three different mono-allelic mutations in the PHD1 finger (p.C311Y, p.V301M, and p.C302Y) segregated with clear but varying autoimmune phenotypes, ranging from late-onset classical APS-1 (e.g., I:3, Figure 1A ) to APS-2 (Table 1, Figure 4B , and Table S1 ) and isolated organ-specific autoimmunity (e.g., vitiligo, PA, and APS-1-specific autoantibodies).
Increased Frequency of Dominant PHD1 Mutations in Various Forms of Organ-Specific Autoimmunity
The above findings raised the question whether dominant PHD1 mutations could generally cause organ-specific autoimmunity. To answer this question, we sequenced the full exon 8 (encoding the PHD1 finger) in several autoimmune patients and controls available from our national registry. We first analyzed the presence of PHD1 mutants in familial cases characterized by the presence of adrenal insufficiency, autoimmune thyroid disease, and/or type 1 diabetes (i.e., APS-2 and/or APS-3). Indeed, among 41 such families, we identified one family with three family members bearing a mono-allelic c.977C>T (p.P326L) mutation (Table 1 [ family F], Figure 4A , and Table S1 ). The mother (II:3) was diagnosed with autoimmune thyroid disease, adrenal insufficiency, pernicious anemia, and vitiligo. Both of her children acquired vitiligo at 10 (III:1) and 7 (III:2) years of age, respectively.
Furthermore, because pernicious anemia, vitamin B12 deficiency, and/or vitiligo seemed to be often associated with heterozygous PHD1 mutations in previous cases ( Figure 4B ), we Risk assessment for HLA genotypes were defined as in Erichsen et al. (2009) . Full HLA class II haplotypes are given in Table S4 . The genotypes conferring ''very high'' and ''high'' risk of developing AI also confer increased risk of developing PA (Lahner et al., 2010) .
f Initially positive for autoantibodies against AADC, but negative in recent samples.
g Immunofluorescence testing for adrenal, ovarian, and pituitary autoantibodies was negative, as were anti-mitochondrial, anti-smooth muscle, and thyroid peroxidase (TPO) autoantibodies. The patient previously tested positive for autoantibodies against tyrosinase and tyrosinase-related protein 1 and 2.
next screened large cohorts of patients with these conditions. Among 177 probands and 26 affected relatives with pernicious anemia, we identified several dominant-negative PHD1 mutants. First, we identified a patient with a heterozygous c.913G>A (p.G305S) mutation who was intrinsic factor (IF) antibody positive and developed severe anemia and neuropathy at age 43 (Table 1 [ family G], Figure 4A , and Table S1 ). Her mother (II:2) and maternal grandfather (I:1) were reported to have pernicious anemia, and the mother also suffered from hypothyroidism and cirrhosis. Her sister (III:3) with p.G305S reported no autoimmunity. p.G305S is close to the zinc binding site and predictably disrupts the zinc finger structure. Not surprisingly, the dominant-negative effect on gene transcription was evident (Figures 2B and S3 and Table S2 ). Another patient in this cohort developed intrinsic factor antibody-positive pernicious anemia at age 81 years and was heterozygous for both c.946C>T (p.R316W) and the common c.967-979del13bp (p.C322del13) mutation on the same allele (Tables 1 and S1 [subject H]). Both (B) The AIRE-regulated gene KRT14 (red bars) and CCNH not regulated by AIRE (blue bars). Transcriptional regulation by WT AIRE and mutants was performed as described in Figure 1B . The results are shown as fold difference (FD) compared to cells transfected only with WT AIRE (dotted line), error bars representing SEM, of two independent experiments. *p < 0.05, **p < 0.0001. See Figure S3 and Table S2. p.R316W and p.C322del13 were predicted to have a partial dominant-negative effect. Similarly, among 170 patients with isolated and familial (n = 64) vitiligo, a female who developed acrofacial vitiligo at age 21 years had gastric parietal cell autoantibodies, low normal serum vitamin B12 level, and a heterozygous mutation in c.983G>A (p.R328Q) (Tables 1 [subject I] and S1). Like p.P326L, a mutation in this C-terminal part of PHD1 does not disrupt the histone binding site but still displays an incomplete inhibition of AIRE-dependent gene transcription (Figures 2B and  S3, Table S2 ). AIRE sequencing revealed that the patient also had p.V484A, a sequence variant that has been described in a patient with alopecia and nail dystrophy (Buzi et al., 2003) . We were unfortunately unable to perform an allele discrimination assay in this patient.
Importantly, sequencing of 450 control blood donors did not reveal the presence of any of the dominant-negative PHD1 mutations and demonstrated that dominant PHD1 mutations were clearly over-represented among patients suffering from various forms of organ-specific autoimmunity. Based on the above data, we propose that heterozygous mutations in the PHD1 domain of AIRE exert a dominant-negative effect on WT AIRE ( Figure 5A ) and that APS-1 can be divided into classical (recessive) and non-classical (dominant) forms ( Figure 5B ).
The Frequency of Dominant-Negative PHD1 AIRE Mutations in Populations
To better estimate the frequency of some of the dominantnegative PHD1 AIRE mutations, we analyzed multiple exome chip datasets that were available, containing some of the PHD1 AIRE sequence variations. Specifically, sequence analysis from existing exome chip datasets from a total of 1,670 Scandinavian individuals (healthy controls [n = 637] and patients with attention deficit [n = 589] or movement disorders [n = 444]) revealed the minor allele frequency of p.V301M to be 0.00089 (i.e., 3 out of 1,667 persons), whereas other covered alterations (p.G303S, p.R303Q, and p.R257*) were not found. The relatively high frequency of the p.V301M dominant mutant was further validated by additional datasets obtained from mixed populations in public databases, including the recently published data from The Broad Institute (covering more than 60,000 individuals; Exome Aggregation Consortium [ExAC] , http://exac.broadinstitute.org), 1000 Genomes database (http://www.1000genomes.org), and the Washington Database ($6,000 individuals; Exome Variant Server, NHLBI GO Exome Sequencing Project [ESP] , http://evs.gs. washington.edu/EVS/). All of the above databases confirmed and broadened these findings and demonstrated that dominant-negative PHD1 mutations were present with minor allele frequency reaching 0.0009 (mainly p.V301M and p.R303Q) in the general population (Table 2 ). It should be stressed, however, that most of the dominant-negative PHD1 variants were not covered on these exome chips, suggesting that the actual frequency might be even higher.
DISCUSSION
Many proteins are active only in the form of a multimeric complex, composed of two or more copies of the same protein. It is well established that in many of these cases, mono-allelic mutations can completely or partially disrupt the structure and thereby the activity of the entire multimeric complex in a dominant-negative manner. Because AIRE is shown to form a homo-tetramer in vivo (Kumar et al., 2001) , it is rather surprising that only one mono-allelic mutation in the AIRE locus has been linked to APS-1 and/or other forms of organ-specific autoimmune disorders so far. We identified several novel heterozygous missense mutations in AIRE, primarily clustered within its PHD1 zinc finger, that were characterized by dominant inheritance, later debut, milder phenotypes, and reduced penetrance. Interestingly, most autosomal-recessive missense mutations causing APS-1 are predominantly found within the CARD domain , which suggested that the recessive or dominant character of a given mutation is, to a large extent, determined by its position within the AIRE protein. This probably reflects the different and unique roles of the individual domains of the AIRE protein. Specifically, whereas the CARD domain is shown to be critical for AIRE homo-oligomerization and speckled nuclear localization (Bjö rses et al., 1999; Kumar et al., 2001) , the PHD domain of AIRE functions as an epigenetic reader, specifically recognizing unmethylated lysine 4 on histone 3 (H3K4me0) . The PHD1 domain is shown to be absolutely critical for AIRE's transcription-transactivation activity, as well as for its capacity to prevent multiorgan autoimmunity in transgenic mouse models Koh et al., 2008 Koh et al., , 2010 . In silico simulations revealed that the PHD1 residues N295-C310 were important in the intermolecular interactions with histone H3 residues. PHD1 is unable to interact with H3K4me0 if the zinc chelating cysteines are mutated, as is the case for C311Y (Bottomley et al., 2005) . The formation of salt bridges between the side chains of H3 residue R2 and D312 is shown to be crucial for binding specificity (Koh et al., 2008) , explaining why the structure is highly conserved in AIRE among different species and also in PHD-zinc finger domain-containing proteins.
Unlike the PHD1 mutants, mutations clustered within the CARD domain of AIRE did not exert any dominant-negative effect. In homozygotes, these mutations impact AIRE oligomerization and correct nuclear localization (Bjö rses et al., 1999; Kumar et al., 2001; Pitkä nen et al., 2001 ), yet they might be able to form oligomers when expressed along with WT AIRE. Interestingly, truncating AIRE mutations such as p.R257* and p.C311* also behaved in a recessive manner, in spite of their ability to colocalize and interact with WT AIRE. This suggested that the above truncations do not disrupt the core structure of the AIRE complex, necessary for its biological activity. Such core structure probably involves formation of functional dimers within the truncated tetramer.
It is therefore not entirely surprising that mono-allelic and dominant-negative mutations in this domain impacted the structure and thus the activity of the entire AIRE tetramer. However, such dominant effects seemed to follow incomplete inheritance, because most of the patients developed milder phenotypes with later onset compared to patients with See also Figures S4 and S5 and Tables S2 and S3. classical, autosomal-recessive APS1. This could be because the AIRE tetramers still have some residual activity, and/or that some pure WT AIRE tetramers were still formed and were sufficient to induce some level of self-tolerance. Moreover, the extent of the dominant effect seemed to depend on which residue is mutated. Our results suggested that mutations in residues 302 and 311 resembled more classical APS-1 than other mutations, although we observed large diversity within the two families with p.C311Y studied here. The genetic contribution of AIRE to autoimmune diseases other than APS-1 has been studied by us and others, but in most cases only SNPs or a few common mutations are analyzed, thereby overlooking rare mutations or large deletions (Jin et al., 2007; Pforr et al., 2006; Thomson et al., 2007; Tö rö k et al., 2004; Turunen et al., 2006; Vaidya et al., 2000) . Although some heterozygous mutations in AIRE are associated with autoimmunity in single patients, a dominant-negative effect on AIRE function was not considered in these cases. Here, we demonstrated that the heterozygous variants observed in the families as well as other mutations analyzed within AIRE exon 8 had an inhibitory effect on AIRE-mediated transcription. This contrasts to classical APS-1 with recessive inheritance and early presentation (mean age 9.1 years, 90% develop all three components by age 20 years) (Wolff et al., 2007) . Organspecific autoimmunity in the heterozygous cases presented later (mean age 24.4 years, n = 12) and progressed more slowly, fewer patients developed the diagnostic dyad, and the penetrance was incomplete. This is reminiscent of autoimmune lymphoproliferative syndrome, which shows 60% penetrance among family members harboring the same heterozygous gene mutation (Price et al., 2014) , or to the incomplete penetrance seen in families carrying heterozygous CTLA4 mutations (Kuehn et al., 2014) . More importantly, the unusual heterozygous cases might not even be recognized as APS-1 because many patients masqueraded as common types of organ-specific autoimmunity in one or several organs. Thus, the original classification of APS-1 as a strictly autosomal-recessive disease (with one exception [Cetani et al., 2001] ) is obsolete. Instead, we propose that APS-1 exists in two forms: (1) ''classical,'' characterized by recessive inheritance, presence of at least two of three main components, and interferon antibodies; and (2) ''non-classical,'' characterized by dominant heterozygous mutations mainly in AIRE's PHD1 zinc finger and a milder, less penetrant autoimmune phenotype. Families with dominant clustering of organ-specific autoimmunity, especially when pernicious anemia and/or vitiligo manifests at early age, might have such mutations, although the clinical phenotype might be expanded when larger materials are investigated. Furthermore, it is reasonable to assume that mutation carriers have a significant risk for polyendocrinopathy, which should be reflected in their follow-up programs. Moreover, autoantibodies against interferons, hallmarks of classical APS-1, were much less prevalent in the non-classical form, probably reflecting some residual AIRE function at least for some of the PHD1 mutations.
Because deep DNA sequencing of thousands of different patients was beyond the scope of the current study, we cannot provide accurate estimates of the prevalence of non-classical APS-1 because a population cohort with autoimmune phenotypes was not available. Based on our own data and publicly available databases representing healthy individuals and patients with various non-autoimmune conditions in different ethnic groups, a conservative estimate puts dominant AIRE mutations at a genotype frequency of one to two persons per thousand in the general population, not restricted to Scandinavia as indicated in literature reports (Cervato et al., 2010; Ferrera et al., 2007; Stolarski et al., 2006; Vogel et al., 2001) . However, further studies are needed to establish the prevalence and risk associated with mutations in the PHD1 domain in larger populations.
In conclusion, this study demonstrates that AIRE mutations associate with common organ-specific autoimmunity with a variable phenotype ranging from classical APS-1 to a non-classical form that mimics common organ-specific autoimmunity. Finally, our study provides important insights into the molecular mode of action of the AIRE protein and highlights unique structural properties that are required for AIRE's biological activity. Table S1 .
EXPERIMENTAL PROCEDURES Patients and Healthy Subjects
A detailed description of patient and control cohorts is given in the Supplemental Data. Use of human material was approved by local ethics committees and all individuals included signed informed consent.
AIRE Sequencing, Copy-Number Analysis, and Microsatellite Typing DNA was extracted from patient or control EDTA blood samples according to standard protocols. All patients and controls were analyzed for nucleotide changes in AIRE (GenBank: AJ009610) exon 8, which contains the PHD1 domain. The 14 exons in AIRE were sequenced in the patients with nucleotide changes in exon 8 by PCR and sequencing as previously described (Wolff et al., 2007) . Copy-number analysis was performed by duplex TaqMan realtime PCR assay as described previously (Bøe Wolff et al., 2008) , using primers and probes for AIRE exon 1 and 9. In brief, a duplex TaqMan real-time PCR assay measured the fluorescent signal from the target (AIRE) and the reference gene (RNaseP [Ribonuclease P]) (Applied Biosystems), detected using different probes. RNasP is known to present in two copies in the genome, and using a standard curve for each gene the number of AIRE copies was calculated as the relative relationship between the signals from AIRE and RNaseP. Microsatellite typing of the AIRE region was performed according to Myhre et al. (2004) . The samples used to estimate population frequencies for AIRE mutations were genotyped on HumanExome 12v1_B (ADHD study) and HumanCoreExome 12v1-1 (movement disorders study) Bead chips, respectively (Illumina).
Assay of Autoantibodies
Autoantibodies against interferon (IFN)-u, IFN-a2, interleukin (IL)-17F, IL-22 , and organ-specific enzymes typical of APS-1 were assayed by radioligand binding assays based on in vitro transcribed and translated proteins, as previously described (Husebye et al., 1997; Oftedal et al., 2008) .
Plasmid Construction
The plasmids svPoly and pEGFP-C1 containing human wild-type (WT) AIRE and AIRE-C311Y, respectively, were kind gifts from Dr. Ismo Ulmanen (Department of Molecular Medicine, National Public Health Institute). Human WT AIRE was also contained in pTagRFP-C vector (Evrogen) by subcloning. The different mutations in AIRE were introduced by site-directed mutagenesis (QuikChange II Site-Directed Mutagenesis Kits [Agilent Technologies]) using primers designed by the web-based program PrimerX (http://www. bioinformatics.org/primerx/) (see Supplemental Experimental Procedures for primers). All plasmids were verified by sequencing.
Transfection and RNA Extraction 4D6 cells, a kind gift from Professor Christophe Benoist (Harvard Medical School), were grown in RPMI 1640 (Sigma-Aldrich) supplemented with 10% (v/v) fetal bovine serum, 10 mM HEPES buffer, 1% (v/v) non-essential amino acids (Lonza), 2 mM L-glutamine (Lonza), 100 U/ml penicillin, and 100 mg/ml streptomycin (Lonza) at 37 C with 5% CO 2 in a humidified incubator. For transfection, cells were plated at a density of 5 3 10 5 cells per well in a 6-well plate and left overnight. Samples (3.3 mg) of the svPoly plasmids were added to a total volume of 157 ml supplemented RPMI 1640 (without penicillin or streptomycin), mixed with 8.3 ml of Fugene HD transfection reagent (Promega Corporation), and incubated for 5 min at room temperature before being added to the cells. The cells were then incubated for 24 hr before total RNA was extracted by RNeasy Mini Kit (QIAGEN) according to the manufacturers' protocol, including in-column DNase treatment. cDNA was prepared from 1 mg of total RNA via a High Capacity RNA-to-cDNA Kit (Applied Biosystems).
Assay of AIRE-Regulated Genes
Genes previously shown to be regulated by AIRE (Abramson et al., 2010) were analyzed by quantitative PCR using the following primers and probes (Applied Biosystems): S100 calcium binding protein A8 (S100A8) (Hs0037444264_g1), keratin 14 (KRT14) (Hs00265033-m1), IGF-like family member 1 (IGFL1) (Hs01651089-g1), and AIRE (Hs01102906-g1 and Hs01102908-g1). Results were compared to beta2-microglobulin (B2M) (4333766) as endogenous control, and the AIRE-independent genes cyclin H (CCNH) (Hs00236923_m1) and protein arginine methyltransferase 3 (PRMT3) (Hs00411605_m1). Datasets of each primer pair were normalized to B2M. Ct values from cells transfected with svPoly harboring the different mutations or the empty svPoly plasmid were then subtracted from the Ct values obtained after transfection with svPoly harboring WT-AIRE. To mimic a heterozygous state, and evaluate the effect of gene dosage, WT-AIRE and AIRE mutants (G228W-AIRE, R257*-AIRE, C311Y-AIRE, and L28P-AIRE) were transfected in ratios of 50% to 75% WT-AIRE. For the rest of the mutants, they were transfected as 100% mutant or 50% mutant with 50% WT AIRE. The fold difference was calculated as 2 À {Ct((target gene) À Ct(B2M)) À (Ct(test sample) À Ct(calibrator sample))}, with test samples defined as the different mutants of AIRE and calibrator as WT-AIRE. The results are shown as the mean of minimum two biological parallels, and a two-tailed t test (GraphPad Prism v.5.02) was used for p values.
Immunofluorescence Human 4D6 cells were plated on 18-mm sterile coverslips in 6-well plates at a density of 5 3 10 5 cells per well and allowed to grow overnight. The cells were then transfected with human EGFP-AIRE and/or RFP-AIRE fusion plasmids using Fugene HD transfection reagent according to the manufacturers' Figure 5 . Dominant Mutations in AIRE and Organ-Specific Autoimmunity (A) Schematic illustration of recessive and dominant AIRE mutations. The homozygous p.R257* truncated protein can form oligomers, but they lack critical domains. In the heterozygous state, p.R257* does not interfere with WT AIRE. PHD1 mutants can form oligomers but AIRE lacks transcriptional activity because of its putative interaction with WT AIRE. Formation of a small fraction of WT:WT oligomers might account for some induction of tolerance and a milder autoimmune phenotype. (B) Manifestations and autoantibodies in patients with recessive (from Meager et al., 2006; Perheentupa, 2006; Wolff et al., 2007) and dominant (this study) mutations. Abbreviations are as follows: AI, adrenocortical insufficiency; CMC, chronic mucocutaneous candidiasis; HP, hypoparathyroidism; PA, pernicious anemia; V, vitiligo. This table shows the allele count, allele number, and minor allele frequency (MAF) of AIRE PHD1. Data are obtained from different sources: the Norwegian exome data are from healthy controls and patients with ADHD and movement disorders, the ExAC Browser includes 60,706 unrelated individuals from various disease-specific and population studies, the Genome Variant Server includes sequences from 6,503 individuals with heart, lung, and blood disorders, and the 1000 Genomes Project includes 2,577 individuals with a mixed background. Abbreviations are as follows: NA, not analyzed in this dataset; ND, no frequency determined. a
The majority mutations are found in European (minus Finnish), followed by Finnish, South Asian, and African populations. The majority mutations are found in European (minus Finnish), followed by Latino populations. The majority mutations are found in European (minus Finnish), followed by South Asian population. The majority mutations are found in European (minus Finnish), followed by Finnish population.
protocol. In brief, plasmid DNA was mixed with transfection reagent at a ratio of 1:2.5 in 157 ml Opti-MEM I Reduced Serum Medium (Invitrogen) and incubated for 7 min at room temperature before being added to the cells. After 24 hr, the cells were washed with PBS (Lonza) and fixed in 4% (w/v) paraformaldehyde in PBS for 7 min. Finally, the cells were washed thoroughly with PBS and ultrapure water before being mounted onto SuperFrost microscope slides (Thermo Fisher Scientific) with ProLong Gold Anti-Fade Reagent with DAPI (Invitrogen). Slides were examined under a Zeiss LSM 510 META Laser Scanning confocal microscope equipped with a 633 Plan-Achromat objective, and images acquired by excitation at 405 nm (DAPI), 488 nm (EGFP), and 543 nm (RFP). The imaging was performed at the Molecular Imaging Center (Fuge, Norwegian Research Council), UiB, Norway.
Protein Analysis
To verify protein expression, single transfection with WT AIRE, C311Y, R257*, and G228W were followed by cell lysis by Complete Lysis-M (Roche Diagnostics GmbH), SDS-PAGE, and immunoblot. AIRE polyclonal anti-AIRE antibody (goat) (1:100 dilution) (Abnova) was used as primary antibody (result not shown).
Structure Modeling
Sequence alignment was made with Clustal Omega Multiple sequence alignment tool (http://www.ebi.ac.uk/Tools/services/web/toolform.ebi?tool= clustalo). Modeling of PHD1 was performed with PyMOL and the coordinates of PDB: 1XWH (Bottomley et al., 2005) . and Musco et al.(Musco and Peterson, 2008) . At age 11 years, he was diagnosed with severe pernicious anemia due to autoimmune gastritis; at 12 years he developed vitiligo; hewas otherwise healthy at age 28 years. The maternal grandmother (I:2) was heterozygous for p.C311Y and was diagnosed with pernicious anemia at age 44 and had several autoantibodies characteristic of APS-1. C p.V301M A woman heterozygous for c.901G>A (p.V301M) was diagnosed with adrenal insufficiency (age 17), autoimmune thyroid disease (age 37), and primary ovarian insufficiency (age 39). She also had autoantibodies characteristic of APS-I. Her daughter (this study) had the heterozygous p.V301M mutations, and autoantibodies against IL-17F, but no autoimmune manifestations at age 30 years. Subject D and E A Russian girl was diagnosed with hypoparathyroidism at age 4 years. She displayed autoantibodies against IFN-omega, 21-hydroxylase and NALP-5. Her parents have not yet been investigated. Another girl of Jewish ancestry had hypoparathyroidism (age 4 years) and autoantibodies against interferon omega and NALP-5 and a de novo heterozygous p.C302Y mutation (reported by Oftedal et al, 2008) . F p.P326L The index person (II:3) was diagnosed with autoimmune thyroid disease at age 21, adrenal insufficiency at 25, pernicious anemia at 27, and vitiligo at age 33 years. Her daughter (III:1) acquired vitiligo at age 10, but is otherwise healthy at age 20; her son with p.P326L (III:2) developed vitiligo at age 7 years. Sequencing revealed that both her mother, brother, one sister and a maternal uncle and aunt carried the mutation. The mother had low B12 and gastric parietal cell antibodies, the others were healthy. G p.G305S A female with p.G305S was identified among 177 probands and 26 affected relatives with pernicious anemia, in a group with familial clustering (66/177). She was intrinsic factor (IF) antibody positive and developed severe anemia and neuropathy at age 43. Her mother (II:2) and maternal grandmother (III:2) were reported to have pernicious anemia, both diagnosed before 35 years of age. In addition, the mother suffered from hypothyroidism and cirrhosis. DNA was not available for analysis of these family members. Pure recessive = <10% transcript repressed; Recessive = <50% transcript repressed; Dominant = >50% transcript repressed; Pure dominant = >90% transcript repressi Table S3 , related to Figure 3A and S4. Nuclear localization assayed by microscope after transfection of 4D6 cells The human thymic cell line 4D6 was transfected with WT and different mutated AIRE constructs, either alone or in combination. The cells were evaluated by confocal microscopy and described. Primers were design to alter one to two nucleotides to introduce the proper amino acid change. The altered bases are marked in bold. The 13-bp deletion in AIRE was generated in two rounds of mutagenesis, where the 8-bp del was made first from the WT AIRE template, then this new construct containing the 8-bp del was used as template for a new mutagenesis to give a deletion of 13 base pairs (**). 
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